Survival N | Death N (%) | P value | Crude OR (95%CI) | Adjusted* OR (95%CI) | |
---|---|---|---|---|---|
All (n = 1,881) | 1799 | 82 (4.4%) | |||
Diagnostic Delay | 0.42 | ||||
Continuous†, per Ln(delay-week) | 1799 | 82 (4.4%) | 0.77 (0.57–1.03) | 0.78 (0.58–1.05) | |
≤ 4 weeks | 931 | 44 (4.5%) | 1 | 1 | |
5- ≤ 8 weeks | 479 | 25 (5.0%) | 1.10 (0.67–1.83) | 1.11 (0.67–1.84) | |
> 9 weeks | 389 | 13 (3.2%) | 0.71 (0.38–1.33) | 0.69 (0.37–1.30) | |
Sex | 0.138 | ||||
Men | 1262 | 64 (4.8%) | 1 | 1 | |
Women | 537 | 18 (3.2%) | 0.66 (0.39–1.13) | 0.58 (0.34–1.00) | |
Age, years | 0.010 | ||||
15–34 | 470 | 20 (4.1%) | 1 | 1 | |
35–54 | 731 | 22 (2.9%) | 0.71 (0.38–1.31) | 0.68 (0.37–1.27) | |
≥ 55 | 598 | 40 (6.3%) | 1.57 (0.91–2.7) | 1.64 (0.37–1.27) | |
Sputum grade at diagnosis (n = 1,827) | 0.256 | ||||
Scanty | 119 | 10 (7.8%) | 2.1 (1.01–4.2) | 2.1 (1.02–4.3) | |
1+ | 1028 | 42 (3.9%) | 1 | 1 | |
2+ | 370 | 18 (4.6%) | 1.19 (0.68–2.1) | 1.22 (0.69–2.2) | |
3+ | 230 | 7 (4.2%) | 1.06 (0.53–2.2) | 1.14 (0.56–2.3) |